Genome Medical Holding
$98.6Mtotal raised · 3 rounds on record
$75.3Mlatest round · Venture round · Sep 2024 · 2 yr ago
6backers · Canaan Partners, GV
52team · US Form 5500 (plan participants) · Dec 2025 · -48% in a year
Key facts
These are the key facts about Genome Medical Holding on Alion as of Nov 13, 2026. Genome Medical Holding is headquartered in San Francisco, United States. It was founded in 2016. It has raised $98.6M in 3 funding rounds. The latest round is Venture - Series Unknown of $75.3M, announced in 2024.
- Headquarters
- San Francisco, United StatesAlion company profile, updated Oct 9, 2026
- Founded
- 2016Alion company profile, updated Oct 9, 2026
- Employees
- 200+Alion company profile, an estimated range
- Total raised
- $98.6MSum of 3 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $75.3M · Sep 10, 2024SEC Form D filing · sec.gov
Official records
Funding and backers
Total raised
$98.6M
3 rounds on record
Latest round
$75.3M
Venture round · Sep 2024 · 2 yr ago
Team
52
US Form 5500 (plan participants) · Dec 2025 · -48% in a year
Backers
6
Canaan Partners, GV
The money's age
Long since its last round
26 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Team shrank to 52 was 100 · US Form 5500 (plan participants)
Sep 10, 2024
Raised a round Venture round $75.3M · SEC Form D
May 30, 2019
Raised a round Venture round $23M · SEC Form D
May 31, 2018
Raised a round Convertible Note $223k · SEC Form D
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2024 | $75.3M | — | SEC Form D |
| Venture round | May 2019 | $23M | — | SEC Form D |
| Convertible Note | May 2018 | $223k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Genome Medical Holding Co | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Lisa AldersonExecutive Officer, DirectorSEC Form D
Lisa J. AldersonExecutive Officer, DirectorSEC Form D
Minh MerchantExecutive OfficerSEC Form D
Kristin AshcraftExecutive OfficerSEC Form D
Jill DaviesExecutive Officer, DirectorSEC Form D
Elizabeth MorenoExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
GV People
Lisa Alderson
Executive Officer, Director
Lisa J. Alderson
Executive Officer, Director
Minh Merchant
Executive Officer
Kristin Ashcraft
Executive Officer
Jill Davies
Executive Officer, Director
Elizabeth Moreno
Executive Officer
Mark Sylvester
Executive Officer
Stephen Bloch
Director
Iana Dimkova
Director
Nicholas Naclerio
Director
Randal Scott
Director
Tim Howe
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
LRVHealthVia a fund
Walden Catalyst VenturesVia a fund
Illumina VenturesVia a fund
Kaiser Permanente VenturesVia a fund
Canaan PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Francisco
United States
HQ
200-500 est. staff
How to cite this page
Alion, "Genome Medical Holding: key facts", as of Nov 13, 2026. https://alion.io/company/genomemedical
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0